We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

ORTEXORTEX News
Tracking RPRX? Get live short interest, options flow, and signals on ORTEX.Sign up free →
RP

Royalty Pharma plc (RPRX) short interest & options flow

NASDAQ

Short sellers have been building their position in RPRX steadily over the past month. Shares short now total around 12.7 million, equal to 3.0% of the free float, up roughly 10% over the past 30 days and 2.2% on the week. The lending market tells a different story from the positioning data. Availability is exceptionally loose, with more than 7,100% of outstanding short interest…

Latest pulse12 Aug 2026

RPRX put-call ratio crashes to 0.15, a 4-sigma decline from its 20-day mean of 0.21, signaling extreme bullish sentiment in options markets.

$66.40-0.18% 1d+1.72% 1w+16.17% 1mClose: 3 Nov 2026
Short interest % of float
Low
Live SI on ORTEX →
Cost to borrow
Low
Live CTB on ORTEX →
Availability
High
Live availability on ORTEX →
Market cap
$29.57B
Next earnings
4 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 4 Nov 2026

ORTEX chart of Royalty Pharma plc (RPRX) share price and short interest (% of free float), six months to November 3, 2026

RPRX news and analysis

RSS

No long-form analysis yet for RPRX. Pulse alerts and the live data picture are available on ORTEX.

Open RPRX on ORTEX →

Want the live picture for RPRX?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RPRX — free to start on ORTEX.

Sign up for free →Open RPRX on ORTEX